Bristol Myers Squibb is paying Prime Medicine $110 million upfront to develop reagents for ex vivo T-cell therapies. Prime, ...

Black race and Hispanic ethnicity are associated with higher incidence and prevalence of cystic fibrosis-related diabetes (CFRD).

Prime Medicine will partner with Bristol Myers Squibb (BMS) to develop and commercialize an unspecified number of reagents for ex vivo T-cell therapies through a collaboration that could generate more ...

The firm is focusing on hematology, immunology, and oncology, liver, and lung conditions, while seeking partnerships beyond these core areas.

The high-profile biotech is zeroing in on programs that serve as proof points for its technology, while seeking partners for ...

Prioritizing Set of High Value Programs in Core Areas of Focus; Modularity of Prime Editing Platform Expected to Allow Prime ...

Internal parasites are the bane of most farmers’ existence as they are hard to detect, control, preventor manage. Thankfully, ...

Prioritizing Set of High Value Programs in Core Areas of Focus; Modularity of Prime Editing Platform Expected to Allow Prime Medicine to Generate Follow-on Candidates Rapidly and Efficiently -- -- ...

RA Capital, RTW Investments, Janus Henderson Investors are pouring another $175 million into a radiopharmaceuticals startup.

SIADH (syndrome of inappropriate antidiuretic hormone secretion) leads to hyponatremia water retention in hospitalized or ...

A DOCTOR who removed the wrong organ from a patient has a history of errors and has finally had their license suspended. Thomas Shakvovksy was a practicing Osteopathic Physician at Ascension ...

The World Health Organization estimates that 8–13% of women of reproductive age have PCOS. Other groups have estimated that number to be closer to 20%. Some women may have PCOS and never know it ...